Sertraline selectively inhibited the proliferation of serine synthesis dependent breast cancer, RPL10 R98S T-cell acute lymphoblastic leukemia (T-ALL) cells, and NKX2-1 T-ALL and NSCLC cells. Here, NKX2-1 is linked to acute lymphoblastic leukemia.